Tuesday, November 15, 2005

Combining two new drugs - UCN-01 and MEK 1/2 -may offer breast cancer hope

DeHavilland, November 15, 2005
Combining two new drugs (UCN-01 and MEK 1/2, a protein inhibitor found to block tumour survival pathways) has been shown to kill up to 3/4 of breast tumours in mice and prevent tumours from re-growing. Separately, they killed only a tiny percentage of cancerous cells. These drugs are also part of a modern class of drugs that are less toxic to non-cancerous cells. Three researchers operated the same studies independently and all found similar results. The authors say more research is needed to test the effectiveness of the drug on humans.


Post a Comment

<< Home

/* WebRing Code */